Skip to main content
. 2011 Nov 1;11:470. doi: 10.1186/1471-2407-11-470

Figure 1.

Figure 1

Parallel screening of drugs from the Johns Hopkins Chemical Compound Library as TRAIL sensitizers. PC3-TR human prostate cancer cells were first incubated with drug treatments (10 μM) for 24 hours after which time the media was removed, refreshed and cells were treated with TRAIL (10 ng/mL) for an additional 24 hrs.